Innovating Works

AVANTEA

Desconocido
WhyNotDry: Toward consolidation of germplasm and cell reversible drying through knowledge transfer. AVANTEA SRL participó en un HORIZON EUROPE: HORIZON-MSCA-2022-SE-01 WhyNotDry will deepen our knowledge on reversible drying in cells and germplasm toward the development of a dry biobanking as an alternative...
2023-08-02 - 2027-09-30 | Financiado
POLYBOOST: POLYBOOST Renovating the Polyclonal Immunotherapy AVANTEA SRL participó en un H2020: H2020-SMEInst-2016-2017 Immunotherapy is an essential field of medicine that allows clinicians to stimulate or to suppress the response of our immune system against...
2017-01-31 - 2017-03-31 | Financiado
DRYNET: Setting an interdisciplinary sectorial international research network to explore dry storage as an... AVANTEA SRL participó en un H2020: H2020-MSCA-RISE-2016 The number of biobanks for diagnostic/clinical/biodiversity preservation purposes is increasing exponentially, representing an economic burd...
2016-11-10 - 2022-08-31 | Financiado
EU-rhythmy: Molecular strategies to treat inherited arrhythmias AVANTEA SRL participó en un H2020: ERC-2014-ADG Sudden cardiac death (SCD) is a leading cause of death in western countries: coronary artery disease is the major cause of SCD in older subj...
2015-10-05 - 2021-10-31 | Financiado
ESNATS: Embryonic Stem cell based Novel Alternative Testing Strategies AVANTEA SRL participó en un FP7: "ESNATS aims at developing a novel toxicity test platform based on embryonic stem cells (ESC), especially human ESC (hESC), to accelerate dr...
Financiado
SCR&TOX: Stem Cells for Relevant Efficient Extended and Normalized Toxicology AVANTEA SRL participó en un FP7: In the development of products for use by humans it is vital to identify compounds with toxic properties at an early stage of their developm...
Financiado
EPIHEALTH: Linking perturbed maternal environment during periconceptional development due to diabetes obesity... AVANTEA SRL participó en un FP7: Scientific evidence clearly indicates that ageing and health in adult life is programmed by genetic and epigenetic mechanisms early in life....
Financiado
EPIHEALTHNET: EpiHealthNet AVANTEA SRL participó en un FP7: Scientific evidence clearly indicates that ageing and health in adult life is programmed by genetic and epigenetic mechanisms early in life....
Financiado
MITCARE: Mitochondrial Medicine developing treatments of OXPHOS defects in recombinant mammalian models. AVANTEA SRL participó en un FP7: Mitochondria are the major source of ATP, synthesized by the mitochondrial respiratory chain (MRC) through the process of oxidative phosphor...
Financiado
PLURISYS: Systems biology approaches to understand cell pluripotency Acronym PluriSys AVANTEA SRL participó en un FP7: The PluriSys project is aimed at increasing the fundamental knowledge of basic biological processes of cell pluripotency and differentiation...
Financiado
TRANSLINK: Defining the role of xeno directed and autoimmune events in patients receiving animal derived biopro... AVANTEA SRL participó en un FP7: TRANSLINK is a project devoted to assessing the mid-to long-term risk factors and improve the outcome of animal (bovine/porcine)-derived Bio...
Financiado
FECUND: Optimisation of early reproductive success in dairy cattle through the definition of new traits and... AVANTEA SRL participó en un FP7: Good fertility is essential for the sustainability of livestock production. Of all livestock sectors, fertility of dairy cattle is raising t...
Financiado
XENOISLET: Macroencapsulated Porcine Pancreatic Islets to cure Diabetes Mellitus type 1 2 AVANTEA SRL participó en un FP7: During the last five years, within the EU FP6 Integrated Project XENOME (LSHB-CT-2006-037377), we have convincingly demonstrated in primates...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.